Chiron continues to drop shoes

Chiron continues to drop shoes

Chiron Corp. demonstrated with two new deals last week that it has a clearly delineated vision of where it wants to go and how it wants to get there.

Each deal represented a separate piece of CHIR's strategy. One, with Cephalon Inc., is to gain entry through strategic alliances into emerging technologies; the other, with Houghten Pharmaceuticals Inc., is to build strong patent positions around key technologies.

The CEPH collaboration, for the research, development and marketing of products to treat neurological disorders, continued CHIR's quest for access to

Read the full 929 word article

How to gain access

Continue reading with a
two-week free trial.